David Assis, MD, is a hepatologist who treats patients at Yale New Haven Hospital with liver and digestive diseases. He focuses on chronic liver ailments, as well as liver and digestive complications of cystic fibrosis. He tells his patients, “We will support you throughout this process and use cutting-edge discoveries to offer the best possible care.”

Dr. Assis became a hepatologist because he was fascinated by autoimmune liver diseases. An assistant professor of medicine (digestive diseases) at Yale School of Medicine (YSM), he dedicates his research to investigating the causes, mechanisms and treatment of these diseases. In 2014, he was honored with YSM’s Kushlan Junior Faculty Award for his research work.

A member of the America Association for the Study of Liver Diseases, Dr. Assis is optimistic about developing better treatments for patients. “There is much to be discovered in this field, and we expect to see great progress within the next several years,” he says.

Secretary of the Special Interest Group in Cholestatic and Biliary Disease.: American Association for Study of Liver Diseases (2016 - Present)

Co-leader of the Working Group on Clinical Trial Design.: International Primary Sclerosing Cholangitis Study Group (2016 - Present)

Steering Committee member of the Consortium, which is consists of a group of investigators from multiple academic medical centers throughout the United States and Canada who are committed to open collaboration to improve the study and treatment of patients with autoimmune liver diseases.: North American Consortium for Autoimmune Liver Disease (2014 - Present)

Board Member of Connecticut Chapter of the American Liver Foundation.: American Liver Foundation - Connecticut Chapter (2014 - Present)

Clinical Trials

New treatments for many conditions are tested in clinical trials, which ultimately bring
lifesaving new drugs and devices to the patients who need them most.
By participating in a clinical trial, you may get access to the most advanced treatments
for your condition, and help determine their benefits for future patients.